Major Shareholders

Summary of Issued Securities 

Ordinary Shares

 
Issued shares at 30 June 2020 395,249,198
Employee options over ordinary shares at 30 June 2020

18,632,800

Major Shareholders 
The top 20 shareholders in Pharmaxis Ltd on 30 June 2020 are:

Name

Number Of Shares

'000

% Total 
1. Citicorp Nominees Pty Limited 100,550 25%
2. Arix Bioscience Holdings Limited 43,693 11%
3. National Nominees Limited 25,592 6%
4. HSBC Custody Nominees (Australia) Limited  24,528 6%
5. JP Morgan Nominees Australia Limited 12,130 3%
6. Moggs Creek Pty Ltd (Moggs Creek Super A/C) 7,098 2%
7.  Dr Toby David Cohen 3,616 1%
8. BNP Paribas Nominees Pty Ltd (BNPP NYB Clearing Acc DRP)  2,658 1%
9. Ms Beu Xu + Mr Dongning Wu 2,429 1%
10.  Mr Yingkali Li 2,400 1%
11. Healthcare Management Consulting (Australia) Pty Ltd 2,220 1%
12. Alpha Matilda Trdaing Pty Ltd (Alpha Matlda Superfund A/C) 2,061 1%
13. Pakasoluto Pty Limited (Barkl Family Super Fund) 2,036 1%
14. Joseph Wallace Carson 2,000 1%
15. Mr Warren Patrick Hackett (Warren Hackett S/F A/C) 1,755 0%
16. George Engineering Pty Ltd (PG Super Fund) 1,750 0%
17. Simgon Pty Ltd (RK Super A/C) 1,750 0%
18. Mr Marco Andrea Negro 1,600 0%
19. DR Newnham Super Pty Ltd 1,527 0%
20. Blair House Pty Ltd (Robert Stork SF A/C) 1,500 0%

Note: the above tables are updated after each quarter end

Substantial Shareholders 

Name Percent Date 
BVF Partners LP 21% 30 May 2019
Arix Bioscience Holdings Limited 11% 25 September 2018
D&A Income Limited 7% 28 February 2019

Directors' Interests

Current director's interest notices can be found here: